Activity Stream
@moatrx
• one week ago
Posted a new blog:
UK SICKLE CELL DISEASE LAUNCH READINESS
UK SICKLE CELL DISEASE LAUNCH READINESS
NICE rejected crizanlizumab on cost grounds even with a discount, setting a hard WAC ceiling for the next UK sickle cell entrant.
Hydroxycarbamide remains NHS...
